A method for preventing drug-induced ototoxicity in an individual in need thereof comprising intratympanic administration of a pharmaceutical composition comprising a therapeutic agent selected from a JNK inhibitor, a TRPV modulator, a MET channel inhibitor, and an otoprotectant to the individual in need thereof, wherein the pharmaceutical composition is administered prior to onset of therapy with the drug, and wherein the composition provides sustained release of the therapeutic agent into the ear for a period of at least 5 days after a single administration
We scoured our mailbox and collected the 7 most frequently asked questions on each subject: B12 Vial Details How to Use Safety Ordering & Delivery Benefits & Effects Order B12 Injections Today We feel honored to offer vitamin B12 vials for sale
So when should clinicians choose a GLP-1 pill instead of a weekly injection
UPJ obstruction is diagnosed through imaging and differs from CVS due to its focus on urinary symptoms
Fertility medications when conception was desired
Track all the Digital Health 150 Startups in this report and many more on our platform The 150 private digital health startups working to recreate how healthcare is delivered
